Nurse Practitioner, Psychiatric/Mental Health · Peoria, IL
NPI
1306552872
Since 2023
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2321 N Wisconsin Ave
Peoria, IL, 61603
Phone (309) 680-7600
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$369K
1,761 prescriptions
Company payments, 2025
$1,812
From 16 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kristina L McCue prescribed most often to Medicare patients was Buspirone Hcl, with 132 prescriptions and refills. In total Kristina L McCue wrote 1,761 Medicare prescriptions that cost $369K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Buspirone Hcl Generic | 132 | 158 | 30 | $2,225 |
| Quetiapine Fumarate Generic | 125 | 155 | 19 | $2,030 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 122 | 122 | 15 | $14K |
| Clonazepam Generic | 122 | 122 | 19 | $679 |
| Hydroxyzine Hcl Generic | 98 | 116 | 24 | $1,890 |
| Trazodone Hcl Generic | 84 | 111 | 21 | $834 |
| Escitalopram Oxalate Generic | 57 | 75 | 12 | $560 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 57 | 89 | 13 | $1,084 |
| Lorazepam Generic | 53 | 53 | Under 11 | $314 |
| Aripiprazole Generic | 49 | 84 | 14 | $4,552 |
| Duloxetine Hcl Generic | 42 | 86 | Under 11 | $1,536 |
| Sertraline Hcl Generic | 42 | 55 | Under 11 | $626 |
| Prazosin Hcl Generic | 41 | 53 | 11 | $636 |
| Risperidone Generic | 36 | 40 | Under 11 | $500 |
| Benztropine Mesylate Generic | 36 | 38 | Under 11 | $594 |
Brand drugs: 139 claims; generic drugs: 1,622 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristina L McCue $1,812 ($1,812 in general payments such as food, travel and fees) from 16 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $365.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $365 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 14 | $235 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $218 |
| Axsome Therapeutics, Inc. AXSM | 4 | $178 |
| Abbvie Inc. ABBV | 12 | $175 |
| Indivior Inc. INDV | 7 | $141 |
| Janssen Pharmaceuticals, Inc JNJ | 6 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $98.15 |
| Gilead Sciences, Inc. GILD | 4 | $80.83 |
| Alkermes, Inc. ALKS | 2 | $50.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.